GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (NAS:GRAL) » Definitions » Capital Expenditure

GRAIL (GRAL) Capital Expenditure : $-8.80 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is GRAIL Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

GRAIL's cash flow for capital expenditures for the three months ended in Sep. 2024 was $-1.0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2024 was $-8.80 Mil.


GRAIL Capital Expenditure Historical Data

The historical data trend for GRAIL's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL Capital Expenditure Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23
Capital Expenditure
-15.99 -3.33 -22.86 -12.89

GRAIL Quarterly Data
Dec18 Jun19 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.07 -3.90 -2.55 -1.39 -0.97

GRAIL Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GRAIL Business Description

Comparable Companies
Traded in Other Exchanges
Address
1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.